Respiratory syncytial virus (RSV) immunisation RSV prevention resources and data to assist healthcare providers and the general public RSV – frequently asked questions (FAQs) RSV immunisation products – evaluation and expected access RSV immunisation products – efficacy and safety NCIRS webinar: RSV and older adults NCIRS webinar: RSV and infants RSV vaccine safety data – AusVaxSafety Useful linksAustralian Immunisation Handbook RSV chapter – Australian Government Department of Health and Aged CareATAGI statement on the clinical use of Arexvy (RSV PRE-F3) vaccine for RSV – Australian Government Department of Health and Aged CareArexvy: Australian prescription medicine decision summary – TGABeyfortus: Australian prescription medicine decision summary – TGABeyfortus (nirsevimab) guidance:NSW HealthQueensland HealthWA HealthRSV clinical trial tracker – PATHRSV vaccine safety data – AusVaxSafety News & events News | 30 August 2024 Timor-Leste rolls out HPV vaccination program News | 29 July 2024 Evidence guiding strategy for Solomon Islands National Immunisation Program News | 26 July 2024 WHO, UNICEF call for renewed action as new data reveal uneven global vaccination coverage, immunity gaps News | 28 June 2024 Call for participants: new NCIRS study on possible links between genes and adverse events after COVID-19 vaccination 1592 views
